, Hong Kong
/Stevepb from Pixabay

Hong Leong’s underwriting profitability to continue

Its shift toward fixed-income securities is expected to reduce volatility.

Hong Leong Insurance (Asia) Limited’s (HLIA) balance sheet remains strong, supported by the highest level of risk-adjusted capitalisation as of the fiscal year ending 30 June 2024 (FY 2024), AM Best said.

The company has sustained moderate capital and surplus growth whilst keeping underwriting leverage low. 

It also maintains a healthy solvency ratio above regulatory requirements. However, its reliance on reinsurance and a concentration of investments in real estate remain factors to monitor.  

AM Best expects HLIA’s strong underwriting profitability to continue, driven by double-digit growth in gross premiums written in FY 2024. 

This has been supported by a recovery in domestic helper and travel insurance. 

The company is also focusing on operational efficiency improvements, which should help stabilise its expense ratio and contribute to higher underwriting margins.  

On the investment side, HLIA’s shift toward fixed-income securities is expected to reduce volatility compared to past exposure to listed equities.  

HLIA’s business profile remains modest in Hong Kong’s general insurance market, though it has been expanding into commercial lines through broker channels. 
 

Follow the link s for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.